Finance

Beta
Lists
PYCXF:OTCMKTS
PYC Therapeutics Ltd
$0.96
0.00%
(0.00) 1D
May 21, 9:55:48 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PYCXF...
Mkt. cap
1.21B
Avg. vol.
50.00
Volume
0.00
52-wk high
$1.26
52-wk low
$0.93
Shares outstanding
983.51M
No. of employees
23
Mkt. cap
1.21B
Avg. vol.
50.00
Volume
0.00
52-wk high
$1.26
52-wk low
$0.93
Shares outstanding
983.51M
No. of employees
23
News stories
From sources across the web
About PYC Therapeutics Ltd
CEORohan Hockings
Employees23
Founded2001
Headquarters-
SectorBiotechnology
Websitepyctx.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
5.83M
5.83M
4.45M
4.45M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.17M
17.17M
15.35M
15.35M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.13M
2.13M
1.71M
1.71M
Operating expense
19.30M
19.30M
17.07M
17.07M
Total operating expenses
19.30M
19.30M
17.07M
17.07M
Operating income
-13.47M
-13.47M
-12.62M
-12.62M
Other non operating income
-
-
-
-
EBT including unusual items
-12.57M
-12.57M
-11.56M
-11.56M
EBT excluding unusual items
-12.57M
-12.57M
-11.56M
-11.56M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.37M
-12.37M
-11.41M
-11.41M
Net profit margin
-212.16%
-212.16%
-256.44%
-256.44%
Earnings per share
-
-
-
-
Interest and investment income
910.91K
910.91K
1.07M
1.07M
Interest expense
-16.94K
-16.94K
-11.85K
-11.85K
Net interest expenses
893.98K
893.98K
1.06M
1.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.24M
-13.24M
-12.47M
-12.47M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer